Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.5 (
thrombin
)
33,306
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Binding of 125-I-fibrinmonomer to peritoneal macrophages was investigated in dependence of plasma fibronectin and of its
thrombin
- or plasmin-derived fragments. Plasma fibronectin failed to enhance cell binding of 125-I-fibrinmonomer. In contrast,
30kD
-fragments derived from the N-termini of the fibronectin subunits improved binding considerably. The association with the cell surface was completely inhibited by EDTA, 2-5 mM putrescine and to about 40 per cent by 0.1 mM dansylcadaverine suggesting that a transamidase-catalyzed cross-linking reaction was involved. Thrombin-derived 200kD-remnants of the fibronectin subunit chains failed to mediate cell binding of 125-I-fibrinmonomer provided they had been deprived of residual
thrombin
activity. Otherwise they were active and their activity was inhibited by the thrombin inhibitor hirudin. Plasmin-derived 200 kD-fragments were inactive as well.
...
PMID:Fibrinmonomer binding to macrophages mediated by fibrin-binding fibronectin fragments. 392 11